V
Vericel Corporation (VCEL)
NGM – Real vaqt narxi. Valyuta: USD
32.94
+0.02 (0.06%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
32.94
+0.02 (0.06%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Vericel Corporation, tijorat bosqichidagi biofarmatsevtika kompaniyasi, Shimoliy Amerikada sport tibbiyoti va og'ir kuyishlarni davolash bozorlari uchun hujayrali terapiya va maxsus biologik mahsulotlarni tadqiq qilish, ishlab chiqish, ishlab chiqarish va tarqatish bilan shug'ullanadi. Kompaniya sport tibbiyoti uchun mo'ljallangan MACI, simptomatik va tizzaning bitta yoki bir nechta to'liq qalinlikdagi xaftaga shikastlanishlarini tiklash uchun cho'chqa kollagen membranasidagi avtolog kultural xondrositlarni o'z ichiga olgan autolog hujayrali terapiya mahsulotlarini, og'ir kuyishlar uchun Epicel, kattalar va bolalarda chuqur-dermal yoki to'liq qalinlikdagi kuyishlarni davolash uchun doimiy terini almashtirish bo'yicha gumanitar vositani va NexoBrid, chuqur qisman qalinlikdagi va/yoki to'liq qalinlikdagi termal kuyishlari bo'lgan kattalar va bolalarda nekrozni olib tashlash uchun biologik etim mahsulotini sotadi. Vericel Corporation ilgari Aastrom Biosciences, Inc. nomi bilan tanilgan va 2014-yil noyabr oyida Vericel Corporation nomini o'zgartirgan. Kompaniya 1989-yilda ro'yxatga olingan va Massachusets shtatining Kembrij shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B. | Chief Medical Officer |
| Mr. Dominick C. Colangelo Esq. | CEO, President & Director |
| Mr. Eric Burns | Vice President of Finance & Investor Relations |
| Mr. Jonathan D. Siegal | Principal Accounting Officer, VP & Corporate Controller |
| Mr. Joseph Anthony Mara Jr. | CFO & Treasurer |
| Mr. Michael Halpin | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 10-Q | vcel-20260331.htm |
| 2026-05-01 | 8-K | ef20071924_8k.htm |
| 2026-03-19 | DEFA14A | lvcel2026_defa14a.htm |
| 2026-03-19 | DEF 14A | vcel2026_def14a.htm |
| 2026-02-26 | 10-K | vcel-20251231.htm |
| 2026-01-13 | 8-K | ef20062769_8k.htm |
| 2025-11-06 | 8-K | vcel-20251106.htm |
| 2025-11-06 | 10-Q | vcel-20250930.htm |
| 2025-07-31 | 8-K | vcel-20250731.htm |
| 2025-07-31 | 10-Q | vcel-20250630.htm |
| Mr. Mike Gilligan | Senior Vice President of Sales |
| Mr. Patrick J. Fowler | Senior Vice President of Corporate Development & Strategy |
| Mr. Roland DeAngelis | Chief Marketing Officer |
| Mr. Sean C. Flynn | Chief Legal Officer |